Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

FOSFOMYCIN TROMETHAMINE vs FOTEMUSTINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

FOSFOMYCIN TROMETHAMINE vs FOTEMUSTINE: Safety Overview

Metric FOSFOMYCIN TROMETHAMINE FOTEMUSTINE
Total FAERS Reports 778 264
Deaths Reported 24 40
Death Rate 3.1% 15.2%
Hospitalizations 280 79
Average Patient Age 59.2 yrs 52.0 yrs
% Female Patients 83.9% 48.0%
FDA Approval Date Dec 19, 1996 N/A
Manufacturer Cipla USA Inc. N/A
Route ORAL N/A
Marketing Status Discontinued N/A